The
Report Congenital Heart Disease Global Clinical Trials Review, H1,
2016 provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Congenital
Heart Disease
Global Clinical Trials Review, H1, 2016" provides an overview of
Congenital Heart Disease clinical trials scenario. This report
provides top line data relating to the clinical trials on Congenital
Heart Disease. Report includes an overview of trial numbers and their
average enrollment in top countries conducted across the globe. The
report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor
type. Report also provides prominent drugs for in-progress trials
(based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download Sample copy of this
Report at: http://www.marketresearchreports.biz/sample/sample/724100
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Table Of Content
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top
Five Countries Contributing to Clinical Trials in Europe 11
Top
Countries Contributing to Clinical Trials in North America 12
Top
Five Countries Contributing to Clinical Trials in Middle East and
Africa 13
Top
Countries Contributing to Clinical Trials in Central and South
America 14
Clinical
Trials by G7 Countries: Proportion of Congenital Heart Disease to
Cardiovascular Clinical Trials 15
Clinical
Trials by Phase in G7 Countries 16
Clinical
Trials in G7 Countries by Trial Status 17
Clinical
Trials by E7 Countries: Proportion of Congenital Heart Disease to
Cardiovascular Clinical Trials 18
Clinical
Trials by Phase in E7 Countries 19
Clinical
Trials in E7 Countries by Trial Status 20
Clinical
Trials by Phase 21
In
Progress Trials by Phase 22
Clinical
Trials by Trial Status 23
Clinical
Trials by End Point Status 24
Subjects
Recruited Over a Period of Time 25
Clinical
Trials by Sponsor Type 26
Prominent
Sponsors 27
Top
Companies Participating in Congenital Heart Disease Therapeutics
Clinical Trials 28
Prominent
Drugs 30
Latest
Clinical Trials News on Congenital Heart Disease 31
Mar
23, 2016: Mezzion Pharma Receives Special Protocol Assessment
Agreement From FDA For Udenafil Phase 3 Studies In Adolescents With
Single Ventricle Congenital Heart Disease With Fontan Physiology 31
Clinical
Trial Profile Snapshots 32
Appendix
181
Abbreviations
181
Definitions
181
Research
Methodology 182
Secondary
Research 182
About
GlobalData 183
Contact
Us 183
Disclaimer
183
Source
184
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment